TDC
MDXG icon

Thompson Davis & Co’s MiMedx Group MDXG Stock Holding History

Thompson Davis & Co’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,500
Closed -$18K – 910
2017
Q3 		$18K Buy
+1,500
New +$22.2K 0.03% 511
2015
Q1 		– Sell
-54,883
Closed -$633K – 1225
2014
Q4 		$633K Buy
54,883
+54,133
+7,218% +$535K 0.73% 26
2014
Q3 		$5K Sell
750
-500
-40% -$3.48K 0.01% 884
2014
Q2 		$9K Sell
1,250
-500
-29% -$2.93K 0.01% 500
2014
Q1 		$11K Sell
1,750
-500
-22% -$3.67K 0.02% 474
2013
Q4 		$20K Buy
+2,250
New +$13.8K 0.03% 343

Other funds holding MDXG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Thompson Davis & Co's MDXG Position: Q4 2017 in Review

Thompson Davis & Co sold out of MiMedx Group (MDXG) in Q4 2017, closing a stake of 1,500 shares — an estimated $18K sold.

Thompson Davis & Co first reported a position in MDXG in Q4 2013 and held it in 6 quarters. The position peaked at $633K in Q4 2014. 236 funds tracked by Wall St. Rank hold MDXG as of Q4 2017.

  • Thompson Davis & Co reported no remaining MiMedx Group position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 1,500 MiMedx Group shares in Q4 2017, an estimated $18K.
  • Thompson Davis & Co first reported a position in MiMedx Group in Q4 2013 and held it in 6 quarters.
  • Thompson Davis & Co's MiMedx Group position peaked at $633K in Q4 2014.
  • 236 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.